Scholarly Index
Rita F. Redberg
University of California, San Francisco; 18,779 total citations; 402 total publications; best world rank #61
University of California, San Francisco
18,779Total citations
402Total publications
59H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 829 | US 378 | 98.18 |
| Acute Myocardial Infarction Research | Lifetime | 606 | US 276 | 98.22 |
| Health and Medical Research Impacts | Lifetime | 225 | US 130 | 95.00 |
| Sex and Gender in Healthcare | Lifetime | 61 | US 43 | 95.50 |
| Healthcare cost, quality, practices | Lifetime | 367 | US 205 | 95.55 |
| Pharmaceutical Economics and Policy | Lifetime | 437 | US 207 | 95.07 |
| Biomedical Ethics and Regulation | Lifetime | 371 | US 196 | 92.27 |
| Pharmaceutical industry and healthcare | Lifetime | 237 | US 147 | 92.62 |
| Science, Research, and Medicine | Lifetime | 916 | US 437 | 63.95 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 609 | US 203 | 94.99 |
| Biomedical Ethics and Regulation | 2021-2025 | 107 | US 48 | 88.38 |
| Pharmaceutical Economics and Policy | 2021-2025 | 231 | US 89 | 88.31 |
| Healthcare cost, quality, practices | 2021-2025 | 435 | US 184 | 81.72 |
| Health and Medical Research Impacts | 2021-2025 | 635 | US 360 | 68.57 |
| Quality and Safety in Healthcare | 2021-2025 | 395 | US 66 | 58.84 |
| Pharmaceutical industry and healthcare | 2021-2025 | 394 | US 216 | 48.83 |